Clearbridge Health Limited (FRA:5C6)
Germany · Delayed Price · Currency is EUR 0.0010
0.00 (0.00%)
At close: Jan 30, 2026
Clearbridge Health Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 10.27 | 9.9 | 10.41 | 16.41 | 11.44 | 36.26 | |
Revenue Growth (YoY) | 10.57% | -4.84% | -36.59% | 43.44% | -68.44% | 68.38% |
Cost of Revenue | 5.17 | 5.12 | 5.28 | 6.84 | 5.08 | 22.44 |
Gross Profit | 5.11 | 4.78 | 5.13 | 9.58 | 6.36 | 13.81 |
Selling, General & Admin | 4.92 | 5.11 | 5.58 | 6.21 | 6.77 | 7.95 |
Amortization of Goodwill & Intangibles | 0.01 | 0.01 | 0.01 | 0.06 | 0.11 | 0.65 |
Other Operating Expenses | 2.4 | 2.37 | 3.05 | 3.81 | 3.23 | 4.71 |
Operating Expenses | 8.42 | 8.64 | 9.82 | 11.58 | 11.74 | 17.42 |
Operating Income | -3.32 | -3.86 | -4.69 | -2.01 | -5.38 | -3.6 |
Interest Expense | -0.43 | -0.68 | -0.73 | -0.87 | -1.72 | -2.33 |
Interest & Investment Income | - | 0.02 | 0.17 | 0.08 | 0.05 | 0.13 |
Currency Exchange Gain (Loss) | -0.23 | - | - | - | - | 0.4 |
Other Non Operating Income (Expenses) | 0.23 | 0.26 | -18.77 | 0.28 | -2.88 | 3.06 |
EBT Excluding Unusual Items | -3.74 | -4.26 | -24.02 | -2.52 | -9.93 | -2.34 |
Impairment of Goodwill | - | - | -10.37 | - | - | - |
Gain (Loss) on Sale of Investments | 0.38 | - | -0.15 | -8.77 | -6.62 | 3.31 |
Gain (Loss) on Sale of Assets | - | - | 0.01 | 0.17 | 2.01 | 1.33 |
Asset Writedown | - | - | - | -0.12 | - | -0.12 |
Other Unusual Items | 0.27 | 0.11 | 0.27 | - | 0.97 | -0.06 |
Pretax Income | -3.09 | -4.14 | -34.27 | -11.24 | -13.57 | 2.12 |
Income Tax Expense | -0.02 | 0.07 | -1.9 | 0.19 | 0.32 | 0.04 |
Earnings From Continuing Operations | -3.08 | -4.21 | -32.37 | -11.43 | -13.89 | 2.07 |
Earnings From Discontinued Operations | 0.17 | 0.05 | -0.09 | 1.33 | -3.59 | - |
Net Income to Company | -2.91 | -4.17 | -32.47 | -10.09 | -17.48 | 2.07 |
Minority Interest in Earnings | 0.27 | 0.56 | 0.27 | -1.05 | -2.49 | -1.46 |
Net Income | -2.64 | -3.61 | -32.2 | -11.14 | -19.97 | 0.62 |
Net Income to Common | -2.64 | -3.61 | -32.2 | -11.14 | -19.97 | 0.62 |
Shares Outstanding (Basic) | 1,195 | 687 | 619 | 618 | 617 | 598 |
Shares Outstanding (Diluted) | 1,195 | 687 | 619 | 618 | 617 | 601 |
Shares Change (YoY) | 93.03% | 11.07% | 0.14% | 0.12% | 2.75% | 15.05% |
EPS (Basic) | -0.00 | -0.01 | -0.05 | -0.02 | -0.03 | 0.00 |
EPS (Diluted) | -0.00 | -0.01 | -0.05 | -0.02 | -0.03 | 0.00 |
Free Cash Flow | -1.2 | -2.08 | -3.99 | -2.66 | -3.74 | 1.53 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 | 0.00 |
Gross Margin | 49.71% | 48.26% | 49.27% | 58.35% | 55.61% | 38.10% |
Operating Margin | -32.30% | -38.95% | -45.05% | -12.22% | -47.02% | -9.94% |
Profit Margin | -25.66% | -36.43% | -309.40% | -67.90% | -174.53% | 1.70% |
Free Cash Flow Margin | -11.63% | -21.04% | -38.34% | -16.18% | -32.68% | 4.22% |
EBITDA | -3.1 | -3.56 | -4.36 | -0.34 | -2.37 | 0.17 |
EBITDA Margin | -30.20% | -35.93% | -41.90% | -2.10% | -20.67% | 0.46% |
D&A For EBITDA | 0.22 | 0.3 | 0.33 | 1.66 | 3.02 | 3.77 |
EBIT | -3.32 | -3.86 | -4.69 | -2.01 | -5.38 | -3.6 |
EBIT Margin | -32.30% | -38.95% | -45.05% | -12.22% | -47.02% | -9.94% |
Effective Tax Rate | - | - | - | - | - | 2.03% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.